Bartushak Jaime has filed 7 insider transactions across 2 companies since August 2024.
Most recent transaction: a grant/award of 825000 shares of CITIUS ONCOLOGY, INC. ($CTOR) on September 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Bartushak Jaime | Chief Financial Officer | A | Common Stock | 825000 | $0.00 | 825,000.0000 | 71,552,402 | 9999.99% | 1.15% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Bartushak Jaime | Chief Financial Officer | A | Common Stock | 825000 | $0.00 | 825,000.0000 | 71,552,402 | 9999.99% | 1.15% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Bartushak Jaime | Chief Financial Officer | A | Common Stock | 825000 | $0.00 | 825,000.0000 | 71,552,402 | 9999.99% | 1.15% |
| Dec. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Bartushak Jaime | Chief Financial Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 1,800,000.0000 | 68,053,607 | 28.57% | 0.59% |
| Nov. 7, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Bartushak Jaime | Chief Financial Officer | A | Stock Option (Right to Purchase Common Stock) | 350000 | $0.00 | 1,718,267.0000 | 6,726,999 | 25.58% | 5.20% |
| Aug. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Bartushak Jaime | Chief Financial Officer | A | Stock Option (Right to Buy) | 1400000 | $0.00 | 1,400,000.0000 | 67,500,000 | 9999.99% | 2.07% |
| Aug. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Bartushak Jaime | Chief Financial Officer | A | Stock Option (Right to Buy) | 466667 | $0.00 | 466,667.0000 | 67,500,000 | 9999.99% | 0.69% |